Wednesday, Sep 3, 2025 · SEC filings
What the smart money revealed on Sep 3
899 insider filings came in. We hid 129 planned (10b5-1) sellers and 642 people whose filings were routine, like grants and tax withholding.
3 insiders at Bolt Projects (BLSK) bought $106K of stock
Roles: CEO, CFO, CTO. Several insiders buying in the same few days is rare.
Medalist Diversified REIT (MDRR) Chairman Frank Kavanaugh bought $1.75M
140,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
Biodesix (BDSX) Director Jack Schuler bought $1.5M
3.49M shares on the open market. Not a grant or an option exercise.
Resideo Technologies (REZI) Director Andrew Teich bought $1M
29,460 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 5 checked quarters beat the typical stock 6 months later.
NIQ Global Intelligence (NIQ) Officer James Peck bought $509K
29,500 shares on the open market. Not a grant or an option exercise.
Medpace (MEDP) CEO August Troendle sold $17.8M
Not marked as a planned 10b5-1 sale. Sold 4% of the shares they held directly. Still holds 924,602 shares.
Fabrinet (FN) Director Rollance Olson sold $3.01M
Not marked as a planned 10b5-1 sale. Sold 39% of the shares they held directly. Still holds 14,201 shares.
Cannae (CNNE) Director Frank Martire sold $2.48M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 35 more real buys
Show 71 more real sales
13F season
Holdings as of Jun 30, 2025 were due Aug 14
74 funds have filed. 68 filed for the quarter before.
Biggest real insider buys, Aug 28–Sep 3
Open-market buys by officers and directors, filed in the 7 days up to Sep 3.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.